- Associate Investigator
- University of Adelaide
Prof Kishan Dholakia is an ARC Laureate Fellow at the Institute for Photonics and Advanced Sensing (IPAS), The University of Adelaide.
Kishan is is an exceptional research scientist, leader and mentor of true international standing. He has contributed major advances in the field of biophotonics, extending from fundamental photonics to interdisciplinary science. Kishan has an impressive career total of over 340 research publications, including over 20 in Nature/Science titled journals, a h-index of 91 and in excess of 33,600 citations. He has delivered over 300 invited /plenary/keynote talks at leading international and national conferences in the field.
Kishan has raised over $60M AUD in research funding as lead investigator, and secured over $1.8M AUD in industrial contracts from companies including Boeing USA, M Squared Lasers and Elliot Scientific Ltd. Professor Dholakia also has over 27 patent families filed, 23 of which are licensed, and an impressive track record of translating technology resulting in multi-million dollar in sales of high value light sheet microscopes (since 2017, with M Squared Life) and trapping instruments (since 2004, with Elliot Scientific).
In recognition of his significant achievements, Kishan has been awarded numerous international prizes and Fellowships, including the International Optics and Photonics Society (SPIE) Dennis Gabor Award (2018), the Institute of Physics Thomas Young Medal and Prize (2017), the Optical Society’s R. W. Wood Prize (2016), the Royal Society London Wolfson Merit Award (2008-2013) and the European Optics Prize (2003). His work on fundamental physics is also cited in the Guinness book of World Records in 2015 for the fastest ‘man-made’ rotation.
Kishan Dholakia is Professor at the University of St Andrews, Scotland. At the University of St Andrews, Professor Dholakia founded the area of biophotonics, establishing the now internationally renowned Centre of Biophotonics. Most recently, he was instrumental in the formation of the James Mackenzie Institute for Early Diagnosis in 2019.